Hematology
-
ADCETRIS (Brentuximab Vedotin) – CD30-positive lymphoma | HongKong DengYue Medicine
-
Ascentage (Lisaftoclax) – CLL/SLL | HongKong DengYue Medicine
-
Xpovio (Selinexor) – MM & DLBCL | HongKong DengYue Medicine
-
Xospata (Gilteritinib) – AML | HongKong DengYue Medicine
-
Tibsovo (Ivosidenib) – AML | HongKong DengYue Medicine
-
DOPTELET (Avatrombopag) – ITP | HongKong DengYue Medicine
-
Pepaxto (Melphalan Flufenamide) – Myeloma | HongKong DengYue Medicine
-
Pemazyre (Pemigatinib) – Cholangiocarcinoma | HongKong DengYue Medicine
-
BENLYSTA (Belimumab) – Lupus Nephritis | HongKong DengYue Medicine
-
Praxbind (Idarucizumab) – Dabigatran Toxicity | HongKong DengYue Medicine
-
Ryzneuta (Efbemalenograstim Alfa)- Febrile Neutropenia Prevention
-
Aiboding (Cladribine) – HCL | HongKong DengYue Medicine
-
Calquence (Acalabrutinib) – CLL | DengYueMed
-
Orelabrutinib – Chronic Lymphocytic Leukemia | DengYueMed
-
Venclexta (Venetoclax) – CLL | DengYueMed
-
Brukinsa (Zanubrutinib) – CLL | DengYueMed
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights